PMA device
Realize Adjustable Gastric Band
Obtech Medical GmbH · Implant, Intragastric For Morbid Obesity (LTI, Class III) · First FDA decision Oct 15, 2008, newest Jul 15, 2011Obesity
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
3
Naming "Realize Adjustable Gastric"
MAUDE reports
5
Brand "Realize Adjustable Gastric", since 2015
PubMed studies
4
Mentioning "Realize Adjustable Gastric"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Realize Adjustable Gastric Band
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- REALIZE ADJUSTABLE GASTRIC BANDPMA supplement
P070009-S011 · Decided Jul 15, 2011 · 178 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- REALIZE ADJUSTABLE GASTRIC BANDPMA supplement
P070009-S003 · Decided Oct 15, 2008 · 180 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bariatric Surgery for the Treatment of Morbid Obesity - Facility Certification RequirementNational analysisReview closedCAG-00250R3Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250R2Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250RUpdated Sep 16, 2026
- Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid ObesityNational determinationOn the books100.1Updated Apr 9, 2025
- Bariatric Surgical Management of Morbid ObesityLocal determinationIn effectL35022Novitas Solutions, Inc.Updated May 7, 2021
- Surgical Management of Morbid ObesityLocal determinationIn effectL33411First Coast Service Options, Inc.Updated Oct 2, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Realize Adjustable Gastric", any status and sponsor, newest update first.
University of MinnesotaAcademic, hospital or other
NCT01882049 · 0 participants · Start May 2016 · Primary completion May 2016
Device: REALIZE Gastric band (ETHICON) · For: OBESITY
Sites: Minneapolis, Minnesota
Ethicon Endo-SurgeryPublic (JNJ)
NCT00543140 · 303 participants · Start Aug 2006 · Primary completion Jan 2015
Device: REALIZE™ Swedish Adjustable Gastric Band · For: Morbid Obesity
Sites: La Jolla, California; Los Angeles, California; Miami, Florida · 8 sites in all
Ethicon Endo-SurgeryPublic (JNJ)
NCT00166205 · 276 participants · Start Jun 2003
Device: Swedish Adjustable Gastric Band · For: Obesity, Morbid
Sites: Los Angeles, California; San Diego, California; Fort Lauderdale, Florida · 12 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Realize Adjustable Gastric", and for the whole product code for context.
This brand
5 reports: 0 malfunction, 5 injury, 0 death
Whole product code LTI
5,233 reports: 2,779 malfunction, 2,372 injury, 70 death
Newest reports for this brand
MW5165630 · Received Feb 4, 2025 · Event dated Jan 22, 2025
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Patient problem as coded: Weight Changes
MW5082880 · Received Jan 4, 2019 · Event dated Dec 10, 2018
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: No Known Impact Or Consequence To Patient
6391526 · Received Mar 8, 2017 · Event dated Feb 6, 2017
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Migration or Expulsion of Device; Unintended Movement
Patient problem as coded: Nausea; Vomiting
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0149-2014 · Started Sep 30, 2013 · Posted by FDA Nov 5, 2013
Reason given: During aging studies, the firm determined that the gastric belts were unable to pass the test requirements established for Force to Lock.
Cause as FDA categorized it: Unknown/Undetermined by firm · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-0150-2014 · Started Sep 30, 2013 · Posted by FDA Nov 5, 2013
Reason given: During aging studies, the firm determined that the gastric belts were unable to pass the test requirements established for Force to Lock.
Cause as FDA categorized it: Unknown/Undetermined by firm · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-0151-2014 · Started Sep 30, 2013 · Posted by FDA Nov 5, 2013
Reason given: During aging studies, the firm determined that the gastric belts were unable to pass the test requirements established for Force to Lock.
Cause as FDA categorized it: Unknown/Undetermined by firm · Device type: Implant, Intragastric For Morbid Obesity (LTI)
16 more recall records with a free account
Published research
The most relevant PubMed records for "Realize Adjustable Gastric"[tiab]. The summary above synthesizes these.
- Safety and effectiveness of REALIZE adjustable gastric band: 5-year prospective study.
Phillips E, Ponce J, Bhoyrul S, et al. · Surg Obes Relat Dis · 2021Multicenter Study
- Clinical outcomes of the Realize Adjustable Gastric Band-C at 2 years in a United States population.
Cunneen SA, Brathwaite CE, Joyce C, et al. · Surg Obes Relat Dis · 2013Evaluation Study, Research Support, Non-U.S. Gov't
- Safety and effectiveness of Realize adjustable gastric band: 3-year prospective study in the United States.
Phillips E, Ponce J, Cunneen SA, et al. · Surg Obes Relat Dis · 2009Clinical Trial, Multicenter Study
- Clinical outcomes of the REALIZE adjustable gastric band-C at one year in a U.S. population.
Cunneen SA, Brathwaite CE, Joyce C, et al. · Surg Obes Relat Dis · 2012Clinical Trial, Multicenter Study
Other devices of this type
Also filed under product code LTI.
- Lap-Band Adjustable Gastric Banding SystemMedtimo, Inc. · PMA 2023
- Obalon Balloon SystemMedtimo, Inc. · PMA 2022
- Orbera Intragastric BalloonBoston Scientific Corporation · PMA 2026
- Bioenterics Lap-Band Adjustable Gastric Banding SystemMedtimo, Inc. · PMA 2003
- ReShape Integrated Dual Balloon SystemBoston Scientific Corporation · PMA 2018
- Allurion Gastric Balloon SystemAllurion Technologies, Inc. · PMA 2026
- Spatz3 Adjustable Balloon SystemSpatz Fgia, Inc. · PMA 2023
- Ethicon Endo-Surgery Curved Adjustable Gastric with Sutureless Port and ApplierObtech Medical GmbH · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.